Relationship between Cognitive Performance and Motor Dysfunction in Patients with Parkinson’s Disease: A Pilot Cross-Sectional Study
Table 2
Correlation matrix for study variables (Spearman’s rho).
Outcome measures
FAB-it
MoCA
TMT-A
TMT-B
SVF
MI
BDI
BBS
10MWT
6MWT
TUG
TUG-COG
UPDRS III
FAB-it
1.000
MoCA
0.715*
1.000
TMT-A
−0.517*
−0.776*
1.000
TMT-B
−0.704*
0.822*
0.740*
1.000
SVF
0.583*
0.778*
−0.579*
−0.729*
1.000
MI
0.596*
0.664*
−0.511*
−0.553*
0.736*
1.000
BDI
0.001
−0.106
0.223
0.030
0.133
−0.029
1.000
BBS
0.790*
0.534*
−0.304
−0.597*
0.371
0.283
−0.114
1.000
10MWT
−0.138
−0.090
0.114
0.308
−0.313
−0.146
−0.371
−0.169
1.000
6MWT
0.149
0.058
−0.129
−0.095
0.292
0.082
−0.014
0.429
−0.715
1.000
TUG
−0.372
−0.564*
0.477
0.630*
−0.713*
−0.243
−0.102
−0.499
0.762*
−0.709*
1.000
TUG-COG
0.190
−0.667*
0.392
0.683*
−0.538
0.101
−0.192
−0.303
0.228
0.027
0.727*
1.000
UPDRS III
−0.281
−0.035
−0.072
0.077
0.088
0.272
−0.103
−0.427
−0.029
0.135
0.074
0.606*
1.000
FAB-it, Frontal Assessment Battery-Italian version; MoCA, Montreal overall Cognitive Assessment; TMT, Trail Making Test; SVF, Semantic Verbal Fluency; MI, Memory with Interference Test; BDI, Beck Depression Inventory; BBS, Berg Balance Scale; 10MWT, 10-Meter Walking Test; 6MWT, 6-Minute Walking Test; TUG, Timed Up and Go Test; TUG-COG, Timed Up and Go Test under dual task condition; UPDRS III, Unified Parkinson’s Disease Rating Scale part III (motor examination). *Significant correlation ().
